Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has issued an announcement.
Kilitch Drugs (India) Limited has submitted its Monitoring Agency Report for the quarter ending September 30, 2025, in compliance with SEBI regulations. This report, prepared by Infomerics Valuation and Rating Limited, reflects the company’s adherence to regulatory requirements and will be available on the company’s website, indicating transparency and accountability to stakeholders.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its commitment to quality and compliance with international standards, as evidenced by its WHO certification.
Average Trading Volume: 3,760
Technical Sentiment Signal: Buy
Current Market Cap: 6.48B INR
See more data about KILITCH stock on TipRanks’ Stock Analysis page.